Literature DB >> 16540035

[Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study].

José V Lozano1, Josep Redón, Luis Cea-Calvo, Cristina Fernández-Pérez, Jorge Navarro, Alvaro Bonet, Jorge González-Esteban.   

Abstract

INTRODUCTION AND
OBJECTIVES: Left ventricular hypertrophy (LVH) is the earliest manifestation of cardiac damage in hypertension. Its appearance is associated with a poor cardiovascular prognosis. The objectives of this study were to determine the prevalence of electrocardiographic LVH and to assess the epidemiological characteristics of hypertensive patients receiving primary care. PATIENTS AND
METHOD: A cross-sectional multicenter study of hypertensive patients aged 55 years or more was carried out in a primary care setting. Blood pressure was measured using the standard method. Cardiovascular history was determined from medical records and LVH was assessed electrocardiographically using Cornell's criteria.
RESULTS: In total, 15 798 patients (mean age 68.0 years, 55.3% women, and 30.4% with diabetes mellitus) were evaluated. Of these, 3207 (20.3%) had electrocardiographic signs of LVH. The prevalence was higher in males, diabetics, smokers, and patients with high blood pressure or renal or cardiovascular disease. Compared to patients without LVH, those with the condition were older, were more often male, and were more likely to have diabetes or renal or cardiovascular disease. Multivariate analysis showed that LVH was independently associated with advanced age, male gender, diabetes, smoking, poor blood pressure control, and the presence of cardiovascular or renal disease. Blood pressure control was poorer in patients with LVH than in those without it.
CONCLUSIONS: The prevalence of electrocardiographic LVH is high, with affected patients being more likely to have diabetes or renal or cardiovascular disease. Moreover, blood pressure control is poor in these patients, and more aggressive pharmacological management is needed.

Entities:  

Mesh:

Year:  2006        PMID: 16540035

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  11 in total

1.  Prevalence and determinants of left ventricular hypertrophy in hypertensive patients at a primary care clinic.

Authors:  Sm Ching; Yc Chia; Wa Wan Azman
Journal:  Malays Fam Physician       Date:  2012-08-31

2.  Blood Pressure Control, Left Ventricular Hypertrophy and Treatment Practice Among Hypertensive Patients in Ethiopia.

Authors:  Daniel Gebrehawaria Kinfe; Gebretsadik Berhe; Kibreab Gidey; Gebre Teklemariam Demoz
Journal:  Int J Gen Med       Date:  2020-10-20

3.  Relationship between electrocardiographic left ventricular hypertrophy criteria and vascular structure and function parameters in hypertensive patients.

Authors:  M A Gómez-Marcos; J I Recio-Rodríguez; M C Patino-Alonso; C Agudo-Conde; E Rodríguez-Sánchez; L Gómez-Sánchez; M Gómez-Sánchez; L García-Ortiz
Journal:  J Hum Hypertens       Date:  2013-09-19       Impact factor: 3.012

4.  [Interobserver agreement on electrocardiographic diagnosis of left ventricular hypertrophy in hypertensive patients in Andalusia. PREHVIA study].

Authors:  Enrique Martín-Rioboó; Amador López Granados; Luis Cea Calvo; Luis Angel Pérula De Torres; Emilio García Criado; Manuel P Anguita Sánchez; Lisardo García Matarín; Rafael Molina Díaz; Tomas Ureña Fernández
Journal:  Aten Primaria       Date:  2009-04-26       Impact factor: 1.137

5.  Association of Endothelial and Mild Renal Dysfunction With the Severity of Left Ventricular Hypertrophy in Hypertensive Patients.

Authors:  Cheng Cao; Jian-Xin Hu; Yi-Fei Dong; Rui Zhan; Ping Li; Hai Su; Qiang Peng; Tao Wu; Xiao Huang; Wen-Hua Sun; Qing-Hua Wu; Xiao-Shu Cheng
Journal:  Am J Hypertens       Date:  2015-07-31       Impact factor: 2.689

6.  Prevalence of target organ damage in hypertensive subjects attending primary care: C.V.P.C. study (epidemiological cardio-vascular study in primary care).

Authors:  Athanasia Papazafiropoulou; Efstathios Skliros; Alexios Sotiropoulos; Christos Papafragos; Aristofanis Gikas; Ourania Apostolou; Hariklia Kaliora; Charalambos Tountas
Journal:  BMC Fam Pract       Date:  2011-07-14       Impact factor: 2.497

7.  Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional study.

Authors:  Luis Cea-Calvo; Pedro Conthe; Pablo Gómez-Fernández; Fernando de Alvaro; Cristina Fernández-Pérez
Journal:  Cardiovasc Diabetol       Date:  2006-11-03       Impact factor: 9.951

8.  Left ventricular hypertrophy among black hypertensive patients: focusing on the efficacy of angiotensin converting enzyme inhibitors.

Authors:  Gari Negeri Jaleta; Esayas Kebede Gudina; Wondim Getinet
Journal:  BMC Res Notes       Date:  2014-01-20

9.  Left ventricular hypertrophy and proteinuria in patients with essential hypertension in Andkhoy, Afghanistan.

Authors:  Mohammad Shoaib Hamrah; Mohammad Hassan Hamrah; Hideki Ishii; Susumu Suzuki; Mohammad Hussain Hamrah; Ahmad Edris Hamrah; Ahmad Elias Dahi; Maimaiti Yisireyili; Naoaki Kano; Kyosuke Takeshita; Mohammad Hashem Hamrah; Junichi Sakamoto; Toyoaki Murohara
Journal:  Nagoya J Med Sci       Date:  2018-05       Impact factor: 1.131

10.  Assessment of Left Ventricular Hypertrophy (LVH) Criteria by Surface Electrocardiography in a Sample of Iraqi Patients with Systemic Arterial Hypertension.

Authors:  Rafid Bashir Altaweel; Maher Abdulla Radhi
Journal:  Med Arch       Date:  2020-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.